BATTILOCCHIO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 916
AS - Asia 261
EU - Europa 231
SA - Sud America 6
Totale 1.414
Nazione #
US - Stati Uniti d'America 907
SG - Singapore 104
CN - Cina 95
FI - Finlandia 54
IN - India 53
IT - Italia 43
DE - Germania 35
UA - Ucraina 33
SE - Svezia 19
BE - Belgio 11
GB - Regno Unito 11
RU - Federazione Russa 11
CA - Canada 8
IE - Irlanda 8
AR - Argentina 5
BG - Bulgaria 5
JP - Giappone 3
KR - Corea 3
IR - Iran 2
CL - Cile 1
ID - Indonesia 1
MX - Messico 1
NL - Olanda 1
Totale 1.414
Città #
Chandler 134
Fairfield 106
Singapore 64
Beijing 58
Ashburn 53
Woodbridge 47
Santa Clara 43
Seattle 41
Wilmington 41
Houston 40
Cambridge 36
Princeton 32
Ann Arbor 31
New York 30
Plano 29
Helsinki 25
Rome 23
Boston 19
Des Moines 14
San Paolo di Civitate 12
Brussels 11
Lawrence 10
Andover 9
Falkenstein 9
Jacksonville 9
Millbury 9
Dublin 8
Toronto 7
Cagliari 6
San Diego 6
Federal 5
Norwalk 5
Sofia 5
Frankfurt am Main 4
Boardman 3
Bühl 3
Guangzhou 3
Los Angeles 3
Mannheim 3
Southend 3
Tokyo 3
Buffalo 2
Chengdu 2
Falls Church 2
Fuzhou 2
Hefei 2
Qingdao 2
San Mateo 2
Shanghai 2
Shenyang 2
Siena 2
Arnsberg 1
Auburn Hills 1
Bengaluru 1
Block 1
Chongqing 1
Dearborn 1
Grafing 1
Henderson 1
Jakarta 1
Kashan 1
Kish 1
Krasnodar 1
Kunming 1
Leawood 1
Luoyang 1
Mexico City 1
Mumbai 1
Nanchang 1
Nanyang 1
Ottawa 1
Oxford 1
Redmond 1
Shenzhen 1
Shijiazhuang 1
Simi Valley 1
Tianjin 1
Xuzhou 1
Yantai 1
Yingkou 1
Totale 1.051
Nome #
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 94
Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach 91
Scale-up of flow-assisted synthesis of C2-symmetric chiral PyBox ligands 89
Flow Based Synthesis of 2-aminoadamantane-2-carboxylic acid 76
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors 73
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 73
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 72
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 71
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents 71
New Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 52
1,5-Diaryl-Pyrroles as New Generation of Anti-Inflammatory and Analgesic Agents: Design, Synthesis, in vitro and in vivo Evaluation 51
Developing New Antiinflammatory and Analgesic Agents: Design, Synthesis, Biological and harmacological Evaluation 46
New 1,5-diphenyl pyrrole derivatives as anti-inflammatory COX-2 selective compounds and their use as potential antitumoral agents. 44
Improving the solubility and the biological profile of a novel class of derivatives as selective COX-2 inhibiting nitric oxide donors 44
Development of a novel class of pharmacodynamic hybrids/no donors that targets cox-2 selectively and a machine-assisted flow procedure for the synthesis of meclinertant, a neurotensin receptor probe 43
BM212 targets MmpL3, Gordon Research Conference on Tuberculosis Drug Development 42
Development of a novel class of derivatives as selective COX-2 inhibiting Nitric Oxide donors: improving the solubility and the biological profile 37
Flow Synthesis and Bio-Pharmacological Studies of an Adamantane Derivative that Shows Analgesic Activity and Inhibits the P2X7-Evoked Glutamate Release 35
New 1,5 diarylpyrrole derivatives as antimycobacterial agents: Design, synthesis, biological evaluation and study of their mode of action 35
Identification of a new Chemical Class of Potent Antimycobacterial Compounds 34
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 32
Novel Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Anti-inflammatory and Analgesic Agents. Synthesis, in vitro and in vivo Biological Evaluation 29
Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 27
New heterocyclic compounds with potential activity against parasitic protozoan: Trypanosoma and Leishmania 27
Synthesis and biological evaluation of new heterocyclic derivatives with potential antimycobacterial activity: systematic approach to lead compound optimization 26
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 24
New Heterocyclic Compounds Targeting Trypanothyione Metabolism in Leishmania Parasites 23
null 22
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action 22
New Pyrrole Derivatives as Anti-inflammatory and Analgesic Agents: Design, Synthesis and Biological Evaluation 20
Totale 1.425
Categoria #
all - tutte 4.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 0 0 24 26 23 49 19 8
2020/202176 12 6 5 13 1 3 0 15 5 9 6 1
2021/2022221 1 19 21 0 34 1 4 22 16 23 20 60
2022/2023315 71 69 5 34 39 34 3 16 32 0 10 2
2023/2024163 13 25 5 7 19 36 1 22 0 13 10 12
2024/2025204 13 44 13 20 37 43 34 0 0 0 0 0
Totale 1.425